Dr. Reddy's Laboratories Limited
NSE: DRREDDY
Employs 28,091 permanent employees and workers, 2.1% on the year before, as filed for the year to 31 Mar 2026 on a group basis. Revenue in the quarter to 30 Jun 2026 was ₹5,137 cr.
Headcount
Annual, from the BRSR filed with NSE (as of 31 March each year)
| As of | Scope | Permanent | Change (%) | Contract / other | Change (%) |
|---|---|---|---|---|---|
| 31 Mar 2022 | Standalone | 20,651 | — | 10,118 | — |
| 31 Mar 2023 | Group⚠ | 25,498 | 4,847(23.5%) | 13,101 | 2,983(29.5%) |
| 31 Mar 2024 | Group | 26,986 | 1,488(5.8%) | 16,883 | 3,782(28.9%) |
| 31 Mar 2025 | Group | 27,517 | 531(2.0%) | 16,035 | −848(5.0%) |
| 31 Mar 2026 | Group | 28,091 | 574(2.1%) | 14,396 | −1,639(10.2%) |
- ⚠The reporting scope changed from the previous period, so the two are not comparable.
Permanent = permanent employees + permanent workers, as defined in SEBI's BRSR. "Standalone" figures cover the listed company alone and exclude its subsidiaries.
Financials (₹ cr)
| Period | Revenue (₹ cr) | Change (%) | Employee cost (₹ cr) | Change (%) | Net profit (₹ cr) | Change (%) | Flags |
|---|---|---|---|---|---|---|---|
| Quarter ended 30 Jun 2026 | 5,137 | 1,315(34.4%) | 967 | 133(15.9%) | 405 | 624(284.5%) | |
| Quarter ended 31 Mar 2026 | 3,822 | −461(10.8%) | 835 | −126(13.1%) | -219 | −310(342.2%) | |
| Quarter ended 31 Dec 2025 | 4,283 | −336(7.3%) | 960 | 92(10.6%) | 91 | −297(76.6%) | |
| Quarter ended 30 Sept 2025 | 4,619 | −3,191(40.9%) | 868 | −19(2.2%) | 387 | −2,574(86.9%) | |
| Quarter ended 30 Jun 2025 | 7,810 | 2,247(40.4%) | 887 | 90(11.3%) | 2,961 | 1,761(146.6%) | |
| Quarter ended 31 Mar 2025 | 5,563 | 548(10.9%) | 797 | 3(0.3%) | 1,201 | 351(41.4%) | |
| Quarter ended 31 Dec 2024 | 5,015 | −1,681(25.1%) | 794 | −46(5.4%) | 849 | −1,033(54.9%) | |
| Quarter ended 30 Sept 2024 | 6,696 | 855(14.6%) | 840 | −16(1.8%) | 1,882 | 465(32.8%) | |
| Quarter ended 30 Jun 2024 | 5,841 | 736(14.4%) | 856 | 76(9.8%) | 1,417 | 382(37.0%) | |
| Quarter ended 31 Mar 2024 | 5,105 | 1,002(24.4%) | 780 | −3(0.4%) | 1,035 | 560(117.8%) | |
| Quarter ended 31 Dec 2023 | 4,103 | −736(15.2%) | 782 | −1(0.2%) | 475 | −717(60.2%) | |
| Quarter ended 30 Sept 2023 | 4,839 | −599(11.0%) | 784 | 44(5.9%) | 1,193 | −447(27.3%) | |
| Quarter ended 30 Jun 2023 | 5,437 | 883(19.4%) | 740 | −25(3.3%) | 1,639 | 967(143.8%) | |
| Quarter ended 31 Mar 2023 | 4,554 | 656(16.8%) | 765 | 57(8.0%) | 672 | 348(107.1%) | |
| Quarter ended 31 Dec 2022 | 3,898 | −983(20.1%) | 708 | −2(0.2%) | 325 | −792(70.9%) | ⚠ |
| Quarter ended 30 Sept 2022 | 4,880 | 1,250(34.4%) | 710 | 61(9.4%) | 1,116 | 617(123.5%) | |
| Quarter ended 30 Jun 2022 | 3,631 | −38(1.0%) | 649 | 40(6.6%) | 500 | 80(19.0%) | |
| Quarter ended 31 Mar 2022 | 3,669 | 189(5.4%) | 609 | 5(0.8%) | 420 | 79(23.0%) | ⚠ |
| Quarter ended 31 Dec 2021 | 3,480 | −344(9.0%) | 604 | −31(4.9%) | 341 | −108(24.0%) | ⚠ |
| Quarter ended 30 Sept 2021 | 3,823 | 390(11.4%) | 635 | 49(8.3%) | 449 | 36(8.6%) | ⚠ |
| Quarter ended 30 Jun 2021 | 3,434 | 83(2.5%) | 587 | 41(7.5%) | 413 | 102(32.7%) | ⚠ |
| Quarter ended 31 Mar 2021 | 3,351 | −58(1.7%) | 546 | −26(4.5%) | 312 | −132(29.8%) | ⚠ |
| Quarter ended 31 Dec 2020 | 3,408 | 62(1.9%) | 572 | −37(6.0%) | 444 | −37(7.8%) | ⚠ |
| Quarter ended 30 Sept 2020 | 3,346 | 101(3.1%) | 608 | 63(11.6%) | 481 | −469(49.4%) | ⚠ |
| Quarter ended 30 Jun 2020 | 3,244 | 393(13.8%) | 545 | 28(5.5%) | 950 | 447(89.0%) | ⚠ |
| Quarter ended 31 Mar 2020 | 2,852 | −192(6.3%) | 517 | 5(1.1%) | 503 | −19(3.6%) | ⚠ |
| Quarter ended 31 Dec 2019 | 3,044 | −402(11.7%) | 511 | 8(1.7%) | 522 | −843(61.8%) | ⚠ |
| Quarter ended 30 Sept 2019 | 3,446 | 937(37.4%) | 503 | 3(0.6%) | 1,365 | 817(149.1%) | ⚠ |
| Quarter ended 30 Jun 2019 | 2,509 | −137(5.2%) | 500 | 10(2.0%) | 548 | 345(170.3%) | ⚠ |
| Quarter ended 31 Mar 2019 | 2,645 | −87(3.2%) | 490 | 18(3.8%) | 203 | −197(49.2%) | ⚠ |
| Quarter ended 31 Dec 2018 | 2,732 | 101(3.8%) | 472 | −31(6.2%) | 399 | 53(15.4%) | ⚠ |
| Quarter ended 30 Sept 2018 | 2,631 | 13(0.5%) | 503 | 36(7.7%) | 346 | 17(5.3%) | ⚠ |
| Quarter ended 30 Jun 2018 | 2,618 | 125(5.0%) | 467 | 4(0.8%) | 329 | 152(86.1%) | ⚠ |
| Quarter ended 31 Mar 2018 | 2,492 | — | 463 | — | 177 | — | ⚠ |
| Period ended 31 Dec 2025 | 16,711 | — | 2,715 | — | 3,439 | — | |
| Period ended 30 Sept 2025 | 12,428 | 3,917(46.0%) | 1,755 | 396(29.1%) | 3,349 | 1,733(107.2%) | |
| Period ended 30 Sept 2022 | 8,511 | — | 1,359 | — | 1,616 | — | |
| Year ended 31 Mar 2026 | 20,533 | −2,583(11.2%) | 3,550 | 262(8.0%) | 3,220 | −2,130(39.8%) | |
| Year ended 31 Mar 2025 | 23,115 | — | 3,288 | — | 5,349 | — |